Title of article
SAR studies: Designing potent and selective LXR agonists
Author/Authors
Jason W. Szewczyk، نويسنده , , Shaei Huang، نويسنده , , Jayne Chin، نويسنده , , Jenny Tian، نويسنده , , Lyndon Mitnaul، نويسنده , , Raymond L. Rosa، نويسنده , , Larry Peterson، نويسنده , , Carl P. Sparrow، نويسنده , , Alan D. Adams، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2006
Pages
6
From page
3055
To page
3060
Abstract
Counterscreening compounds from a Merck PPAR program discovered lead 1, as a nanomolar LXR/PPAR dual agonist. SAR optimization developed a series of heterocyclic LXR agonists having excellent selectivity over all PPAR isoforms and possessing high LXR affinity and strong in vivo potency.
Keywords
SAR study , Small molecule agonist , LXR
Journal title
Bioorganic & Medicinal Chemistry Letters
Serial Year
2006
Journal title
Bioorganic & Medicinal Chemistry Letters
Record number
796926
Link To Document